KLEVA is a privately owned pharmaceutical company. It has been established in Greece since 1974 commercializing proprietary prescription and OTC products. Today KLEVA is one of the most rapidly evolving Greek pharmaceutical companies undertaking research, development and manufacturing of generic products. Kleva has a successful experience in developing generic pharmaceuticals at a European level and in bringing them through the regulatory approval. Kleva is a fully integrated company with: • R&D • RA • Production • QC • QA • Marketing • Sales departments Our factory in Athens-Greece is equipped with the latest technology machinery and has the manufacturing potential for a wide range of pharmaceutical forms following strictly the GMPs specifications, the WHO regulations and according ISO 9001-2008 TUV Austria Certification. Focusing mainly on Pharmaceuticals (Rx & OTC), the company offers a flexible, fully scalable, qualitative and cost effective product development in a wide range of dosage forms. We register and export our products to a number of regulated and non regulated markets around the world . We are looking for: New Markets penetration International Business Development Opportunities Contract manufacturing deals for Rx, OTC and Food Supplement products. Kleva Pharmaceuticals S.A.
View Top Employees from KLEVA Pharmaceuticals S.A.Website | http://www.kleva.gr |
Revenue | $25.9 million |
Employees | 110 (83 on RocketReach) |
Founded | 1974 |
Address | 189 Parnithos Ave, Acharnes - Attiki 136 75, GR |
Phone | +30 21 0240 2404 |
Technologies |
JavaScript,
HTML,
PHP
+15 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
Web Rank | 7 Million |
Keywords | Generic Drugs, European Pharmaceutical Company, Pharmaceutical Quality, Pharmaceutical Research |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular KLEVA Pharmaceuticals S.A. employee's phone or email?
The KLEVA Pharmaceuticals S.A. annual revenue was $25.9 million in 2024.
Antonis Giannopoulos is the International BD Director of KLEVA Pharmaceuticals S.A..
83 people are employed at KLEVA Pharmaceuticals S.A..
The NAICS codes for KLEVA Pharmaceuticals S.A. are [32541, 325, 32, 3254].
The SIC codes for KLEVA Pharmaceuticals S.A. are [283, 28].